Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Future Medicinal Chemistry
|
February 17, 2015
Progress toward JAK1-selective inhibitors
Christel J Menet, Oscar Mammoliti, Miriam López-Ramos
Organic & Biomolecular Chemistry
|
August 8, 2014
Organophosphorus-catalyzed diaza-Wittig reaction: application to the synthesis of pyridazines
Hassen Bel Abed, Oscar Mammoliti, Omprakash Bande, et al.
The Journal of Organic Chemistry
|
August 17, 2013
Strategy for the synthesis of pyridazine heterocycles and their derivatives
Hassen Bel Abed, Oscar Mammoliti, Omprakash Bande, et al.
Frontiers in Pharmacology
|
November 13, 2018
Identification and Characterization of Novel CFTR Potentiators
Maarten Gees, Sara Musch, Steven Van der Plas, et al.
Journal of Medicinal Chemistry
|
January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis
Steven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry
|
May 28, 2024
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases
Oscar Mammoliti, Sébastien Martina, Pieter Claes, et al.
Journal of Medicinal Chemistry
|
May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis
Oscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Bioorganic & Medicinal Chemistry
|
October 24, 2024
Design of a potent and selective dual JAK1/TYK2 inhibitor
Oscar Mammoliti, Christel Menet, Céline Cottereaux, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
Steven E Van der Plas, Hans Kelgtermans, Tom De Munck, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 25, 2025
Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseases
Oscar Mammoliti, Florence Bonnaterre, Gregory Newsome, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Future Medicinal Chemistry
|
February 17, 2015
Progress toward JAK1-selective inhibitors
Christel J Menet, Oscar Mammoliti, Miriam López-Ramos
Organic & Biomolecular Chemistry
|
August 8, 2014
Organophosphorus-catalyzed diaza-Wittig reaction: application to the synthesis of pyridazines
Hassen Bel Abed, Oscar Mammoliti, Omprakash Bande, et al.
The Journal of Organic Chemistry
|
August 17, 2013
Strategy for the synthesis of pyridazine heterocycles and their derivatives
Hassen Bel Abed, Oscar Mammoliti, Omprakash Bande, et al.
Frontiers in Pharmacology
|
November 13, 2018
Identification and Characterization of Novel CFTR Potentiators
Maarten Gees, Sara Musch, Steven Van der Plas, et al.
Journal of Medicinal Chemistry
|
January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis
Steven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry
|
May 28, 2024
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases
Oscar Mammoliti, Sébastien Martina, Pieter Claes, et al.
Journal of Medicinal Chemistry
|
May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis
Oscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Bioorganic & Medicinal Chemistry
|
October 24, 2024
Design of a potent and selective dual JAK1/TYK2 inhibitor
Oscar Mammoliti, Christel Menet, Céline Cottereaux, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
Steven E Van der Plas, Hans Kelgtermans, Tom De Munck, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 25, 2025
Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseases
Oscar Mammoliti, Florence Bonnaterre, Gregory Newsome, et al.
Page
of 2